Genentech announced the launch of All Eyes on DME, a campaign developed in partnership with advocacy group, diaTribe, that harnesses the power of humor to destigmatize and bring attention to diabetes-related vision conditions. The multi-channel campaign features Damon Wayans’ iconic humor and personal diabetes journey, as well as patient perspectives to create a powerful cultural connection and drive actionable conversations about protecting vision from a serious, yet often-overlooked eye condition.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Roche upgraded to Equal Weight from Underweight at Morgan Stanley
- Roche reports Q1 group sales CHF 14.7B vs. CHF 15.4B last year
- Roche expects increase in group sales in mid single digit range for FY26
- Genentech’s treatment of KRAS G12C-positive NSCLC granted FDA orphan designation
- Genetech says Phase III METEROID study of Enspryng meets primary endpoint